Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Abiomed Pumps Up Temporary Heart Assist Offerings With AB5000 Ventricle

This article was originally published in The Gray Sheet

  • News

Executive Summary

Abiomed expects FDA's Sept. 25 approval of a PMA supplement for its AB5000 Ventricle biventricular cardiac assist system to help reinvigorate stagnant temporary cardiac assist capital equipment sales

You may also be interested in...



Abiomed Taps GE Exec Minogue For CEO Slot, Adding Marketing Expertise

Newly appointed Abiomed President & CEO Michael Minogue's goals for 2004 include corporate profitability and a full rollout of the AB5000 Circulatory Support System

Abiomed Taps GE Exec Minogue For CEO Slot, Adding Marketing Expertise

Newly appointed Abiomed President & CEO Michael Minogue's goals for 2004 include corporate profitability and a full rollout of the AB5000 Circulatory Support System

Spinal Implant Sales Make, Break Orthopedic Stocks In September

Biomet's ability to beat Wall Street's first-quarter revenue estimates by roughly $9 mil. due to strong spinal implant sales drove up the company's stock 12.6% in September

Table

View full table

Tags:
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT019061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By